EMX2 and esophageal squamous cell carcinoma: The prognostic significance of EMX2 in ESCC is underscored by our Kaplan–Meier survival analyses, which showed that patients with high EMX2 expression have significantly worse disease-specific survival (DSS), progression-free survival (PFS), and disease-free survival (DFS).